16 July, 2017
SunTrust Banks, Inc. initiated coverage on Exelixis in a report on Thursday. Exelixis Inc now has $7.75B valuation. It closed at $25.42 lastly. Burt Wealth reported 2,250 shares. The shares were sold at an average price of $21.69, for a total transaction of $2,169,000.00. The company's stock has a normal trading capacity of 4.06M shares while the relative volume is 0.74. It has underperformed by 46.86% the S&P500.
Since February 1, 2017, it had 0 insider purchases, and 22 sales for $28.28 million activity.
By historical standards, Exelixis, Inc. (NASDAQ:EXEL) is up 44.60%, compared with a gain of almost 25.35% for 3 months and about 32.05% for the past 30 days. Hessekiel Jeffrey had sold 6,884 shares worth $144,702.
EXEL's fiscal year ends Dec 31, 2016 and the most recent quarter started on Mar 31, 2017.
By having an overview of the Income statement for Exelixis Inc (NASDAQ:EXEL) the Revenue for the trailing twelve months is 256.91 Million. Shares for $879,200 were sold by MARCHESI VINCENT T on Friday, March 10. Highbridge Capital Management has an ownership of 15,223 stocks of the biotechnology firms shares valued $227,000 after scooping up an extra 8,123 stocks in the previous period. $2.30 million worth of Exelixis, Inc.
Investors sentiment decreased to 1.04 in Q4 2016. Its down 1.03, from 2.07 in 2016Q3. 40 funds opened positions while 63 raised stakes. On the bright side, the company's share price has been on the rebound, up more than 232.5% since hitting lows of $7.97 on July 14, 2016. Moreover, Northern Tru has 0.01% invested in Exelixis, Inc. Royal Comml Bank Of Canada has 0% invested in Exelixis, Inc. (NASDAQ:AMSF). Pub Sector Pension Board invested in 13,620 shares or 0.01% of the stock. The shares are at this time trading 5.98% more than its SMA 50 and 4.37% top of its SMA 200. Marco Investment Lc stated it has 3,350 shares.
Investors wait Exelixis, Inc. (NASDAQ:EXEL). Neuberger Berman Grp Incorporated Ltd Com holds 0% or 89,550 shares in its portfolio. $250,800 worth of Exelixis, Inc. (NASDAQ:EXEL) for 586,100 shares. Barclays Public Ltd Co holds 0% of its portfolio in Exelixis, Inc. (NASDAQ:EXEL) or 76,250 shares. The New York-based Retail Bank Of Mellon has invested 0.01% in Exelixis, Inc. (NASDAQ:EXEL). Keybank Natl Association Oh holds 0% or 21,000 shares in its portfolio. For the outlook of the current financial quarter, Analysts think the firm will post 0.03 earnings per share. Globeflex Capital L P holds 0.19% in Exelixis, Inc. The Beta for the company stands at 1.89 and its Average True Range (ATR) shows a value of 0.96. Zacks Investment Research upgraded shares of Exelixis from a hold rating to a strong-buy rating and set a $29.00 price target for the company in a report on Tuesday. Therefore 71% are positive.
Other equities analysts have also issued reports about the stock. The firm has "Outperform" rating by Leerink Swann given on Tuesday, January 19. The company was maintained on Wednesday, June 14 by William Blair. CIBC initiated coverage on Exelixis in a research note on Thursday, March 16th.
Exelixis, Inc. (EXEL) surprised the stock market in its last reported earnings when it earned $0.05 a piece versus the consensus-estimated -$0.01. The company was maintained on Thursday, September 15 by Stifel Nicolaus. The brokerage issued a hold rating on the biotechnology company's stock. TheStreet lifted Exelixis from a "d" recommendation to a "c+" recommendation in a analysis report on Tue, May 2nd. Four research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. Scansource Inc (NASDAQ:SCSC) was reduced too. On Monday, October 10 the stock rating was upgraded by Piper Jaffray to "Overweight". BidaskClub upgraded shares of Exelixis from a hold rating to a buy rating in a report on Friday, June 23rd. The firm earned "Buy" rating on Monday, April 4 by Stifel Nicolaus.
The closing price represents the final price that a stock is traded for on a trading day. As per Tuesday, May 31, the company rating was maintained by Morgan Stanley. Patrick J. Haley, Sr. The shares sold for $21.81. $216,600 worth of stock was sold by PAPADOPOULOS STELIOS on Monday, March 20. JACKSON TIMOTHY E sold 11,002 shares worth $728,756. The insider Schwab Gisela sold $2.07M. Its up 0.40, from 1.01 in 2016Q3. Citigroup stated it has 590,700 shares. Credit Suisse Ag reported 639,712 shares. Sterling Cap Mgmt Ltd accumulated 30,871 shares or 0.02% of the stock. Teacher Retirement Sys Of Texas holds 4,461 shares. Thompson Siegel & Walmsley Limited Liability Corporation stated it has 0% in Tenneco Inc (NYSE:TEN). Marshall Wace Llp owns 317,426 shares or 0.03% of their U.S. portfolio. Scotia Cap reported 0.01% of its portfolio in Tenneco Inc (NYSE:TEN). Pnc Fincl Svcs Grp invested in 244,517 shares. Diamond Hill Cap Mgmt owns 571,921 shares or 0.21% of their U.S. portfolio. Janus Capital Mngmt Llc invested in 0.03% or 1.99M shares. Shares for $1.31M were sold by Lamb Peter on Wednesday, February 1. It also reduced its holding in Allergan Plc by 20,000 shares in the quarter, leaving it with 166,000 shares, and cut its stake in Celgene Corp (NASDAQ:CELG).
What Guru's think About Is Exelixis, Inc. During the same quarter a year ago, the firm posted ($0.27) EPS. EXEL's profit will be $5.83 million for 332.25 P/E if the $0.02 EPS becomes a reality.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.